275 related articles for article (PubMed ID: 29856067)
1. The biomedical challenge of neurodegenerative disorders: an opportunity for cannabinoid-based therapies to improve on the poor current therapeutic outcomes.
Fernández-Ruiz J
Br J Pharmacol; 2019 May; 176(10):1370-1383. PubMed ID: 29856067
[TBL] [Abstract][Full Text] [Related]
2. Anti-tumour actions of cannabinoids.
Hinz B; Ramer R
Br J Pharmacol; 2019 May; 176(10):1384-1394. PubMed ID: 30019449
[TBL] [Abstract][Full Text] [Related]
3. Modeling Neurodegenerative Disorders for Developing Cannabinoid-Based Neuroprotective Therapies.
Fernández-Ruiz J; Gómez-Ruiz M; García C; Hernández M; Ramos JA
Methods Enzymol; 2017; 593():175-198. PubMed ID: 28750802
[TBL] [Abstract][Full Text] [Related]
4. Targeting the CB
Rodríguez-Cueto C; García-Toscano L; Santos-García I; Gómez-Almería M; Gonzalo-Consuegra C; Espejo-Porras F; Fernández-Ruiz J; de Lago E
Br J Pharmacol; 2021 Mar; 178(6):1373-1387. PubMed ID: 33486755
[TBL] [Abstract][Full Text] [Related]
5. Joint problems arising from lack of repair mechanisms: can cannabinoids help?
Malek N; Starowicz K
Br J Pharmacol; 2019 May; 176(10):1412-1420. PubMed ID: 29574720
[TBL] [Abstract][Full Text] [Related]
6. The influence of cannabinoids on generic traits of neurodegeneration.
Fagan SG; Campbell VA
Br J Pharmacol; 2014 Mar; 171(6):1347-60. PubMed ID: 24172185
[TBL] [Abstract][Full Text] [Related]
7. Cannabinoids and their actions: An update.
Alexander SPH; Molina-Holgado F
Br J Pharmacol; 2019 May; 176(10):1359-1360. PubMed ID: 31032895
[TBL] [Abstract][Full Text] [Related]
8. Cannabinoids and neurodegenerative diseases.
Romero J; Orgado JM
CNS Neurol Disord Drug Targets; 2009 Dec; 8(6):440-50. PubMed ID: 19839933
[TBL] [Abstract][Full Text] [Related]
9. Type-2 cannabinoid receptors in neurodegeneration.
Bisogno T; Oddi S; Piccoli A; Fazio D; Maccarrone M
Pharmacol Res; 2016 Sep; 111():721-730. PubMed ID: 27450295
[TBL] [Abstract][Full Text] [Related]
10. The endocannabinoid system in normal and pathological brain ageing.
Bilkei-Gorzo A
Philos Trans R Soc Lond B Biol Sci; 2012 Dec; 367(1607):3326-41. PubMed ID: 23108550
[TBL] [Abstract][Full Text] [Related]
11. Effect of endocannabinoid signalling on cell fate: life, death, differentiation and proliferation of brain cells.
Garcia-Arencibia M; Molina-Holgado E; Molina-Holgado F
Br J Pharmacol; 2019 May; 176(10):1361-1369. PubMed ID: 29797438
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic effects of cannabinoids in animal models of seizures, epilepsy, epileptogenesis, and epilepsy-related neuroprotection.
Rosenberg EC; Patra PH; Whalley BJ
Epilepsy Behav; 2017 May; 70(Pt B):319-327. PubMed ID: 28190698
[TBL] [Abstract][Full Text] [Related]
13. Single and combined effects of plant-derived and synthetic cannabinoids on cognition and cannabinoid-associated withdrawal signs in mice.
Myers AM; Siegele PB; Foss JD; Tuma RF; Ward SJ
Br J Pharmacol; 2019 May; 176(10):1552-1567. PubMed ID: 29338068
[TBL] [Abstract][Full Text] [Related]
14. Cannabinoid pharmacology/therapeutics in chronic degenerative disorders affecting the central nervous system.
Aymerich MS; Aso E; Abellanas MA; Tolon RM; Ramos JA; Ferrer I; Romero J; Fernández-Ruiz J
Biochem Pharmacol; 2018 Nov; 157():67-84. PubMed ID: 30121249
[TBL] [Abstract][Full Text] [Related]
15. Cannabinoids in Neurodegenerative Disorders and Stroke/Brain Trauma: From Preclinical Models to Clinical Applications.
Fernández-Ruiz J; Moro MA; Martínez-Orgado J
Neurotherapeutics; 2015 Oct; 12(4):793-806. PubMed ID: 26260390
[TBL] [Abstract][Full Text] [Related]
16. Cannabinoid receptors and their role in neuroprotection.
van der Stelt M; Di Marzo V
Neuromolecular Med; 2005; 7(1-2):37-50. PubMed ID: 16052037
[TBL] [Abstract][Full Text] [Related]
17. [Neuroprotective mechanisms of cannabinoids in brain ischemia and neurodegenerative disorders].
Osuna-Zazuetal MA; Ponce-Gómez JA; Pérez-Neri I
Invest Clin; 2015 Jun; 56(2):188-200. PubMed ID: 26299059
[TBL] [Abstract][Full Text] [Related]
18. Cannabinoids' Role in Modulating Central and Peripheral Immunity in Neurodegenerative Diseases.
Sharon N; Yarmolinsky L; Khalfin B; Fleisher-Berkovich S; Ben-Shabat S
Int J Mol Sci; 2024 Jun; 25(12):. PubMed ID: 38928109
[TBL] [Abstract][Full Text] [Related]
19. Cannabinoid drugs and enhancement of endocannabinoid responses: strategies for a wide array of disease states.
Karanian DA; Bahr BA
Curr Mol Med; 2006 Sep; 6(6):677-84. PubMed ID: 17022737
[TBL] [Abstract][Full Text] [Related]
20. Opposing roles of CB
Gobira PH; Oliveira AC; Gomes JS; da Silveira VT; Asth L; Bastos JR; Batista EM; Issy AC; Okine BN; de Oliveira AC; Ribeiro FM; Del Bel EA; Aguiar DC; Finn DP; Moreira FA
Br J Pharmacol; 2019 May; 176(10):1541-1551. PubMed ID: 30101419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
